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Background: g-cytoplasmic (g-cyto) actin levels are elevated in dystrophin-deficient mdx mouse skeletal muscle. The
purpose of this study was to determine whether further elevation of g-cyto actin levels improve or exacerbate the
dystrophic phenotype of mdx mice.
Methods: We transgenically overexpressed g-cyto actin, specifically in skeletal muscle of mdx mice (mdx-TG), and
compared skeletal muscle pathology and force-generating capacity between mdx and mdx-TG mice at different
ages. We investigated the mechanism by which g-cyto actin provides protection from force loss by studying the
role of calcium channels and stretch-activated channels in isolated skeletal muscles and muscle fibers. Analysis of
variance or independent t-tests were used to detect statistical differences between groups.
Results: Levels of g-cyto actin in mdx-TG skeletal muscle were elevated 200-fold compared to mdx skeletal muscle
and incorporated into thin filaments. Overexpression of g-cyto actin had little effect on most parameters of mdx
muscle pathology. However, g-cyto actin provided statistically significant protection against force loss during
eccentric contractions. Store-operated calcium entry across the sarcolemma did not differ between mdx fibers
compared to wild-type fibers. Additionally, the omission of extracellular calcium or the addition of streptomycin to
block stretch-activated channels did not improve the force-generating capacity of isolated extensor digitorum
longus muscles from mdx mice during eccentric contractions.
Conclusions: The data presented in this study indicate that upregulation of g-cyto actin in dystrophic skeletal
muscle can attenuate force loss during eccentric contractions and that the mechanism is independent of activation
of stretch-activated channels and the accumulation of extracellular calcium.
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Background
Duchenne muscular dystrophy (DMD) is a severe mus-
cle-wasting disease caused bym u t a t i o n si nt h ed y s t r o -
phin gene. Dystrophin localizes primarily to costameres,
where it links the cortical actin cytoskeleton to the sar-
colemma and the extracellular matrix [1]. It is part of
the dystrophin-glycoprotein complex (DGC), a large oli-
gomeric complex of proteins thought primarily to
stabilize the sarcolemma during muscle contraction. In
the absence of a functional dystrophin protein, myofi-
bers are susceptible to injury, leading to muscle degen-
eration, inflammation and fibrosis.
Dystrophin binds to filamentous actin with high affi-
nity via two distinct actin-binding domains: an N-term-
inal tandem calponin homology domain and a region of
basic spectrin-like repeats in the middle rod domain [1].
In skeletal muscle, dystrophin forms a mechanically
strong link with the cortical actin cytoskeleton, which is
composed of g-cytoplasmic (g-cyto)a n db-cytoplasmic
actins [2,3]. The tight association between dystrophin
and actin has been demonstrated with inside-out peeled
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cyto actin was retained in a riblike costameric pattern
b u ta b s e n tf r o mt h ed y s t r o p h i n - d e f i c i e n tmdx mouse
sarcolemma [2]. The importance of dystrophin-actin
binding in vivo is also evident in transgenic mdx mice
that express various dystrophin deletion constructs.
Despite restoration of DGC members at the sarco-
lemma, at least one actin-binding domain is essential for
partial or complete rescue of the dystrophic phenotype
in transgenic mdx mice [4-6].
A robust phenotype of the mdx mouse is increased
susceptibility to injury following eccentric muscle con-
tractions [7,8], a standard procedure to determine the
efficacy of a drug or therapy in preclinical trials [9].
Force loss following eccentric contractions depends on
the number of contractions, speed of contraction, overall
length change, muscle type and age of the mice. Overall
force loss in WT mice ranges from 2% to 29%, but force
loss can range from 27% to 69% in mdx mice [10]. The
mechanism of force loss following eccentric contractions
in healthy muscle has been investigated. The majority of
force loss following eccentric contractions in an in vivo
rodent model was due to excitation-contraction uncou-
pling, and about 25% of the force loss can be attributed
to physical damage [11]. After the initial bout of injury,
the loss of contractile protein accounts for strength loss
during 14 to 28 days of recovery. It is unknown whether
excitation-contraction uncoupling, physical damage, loss
of contractile protein or a combination of different
mechanisms explains the rapid force loss in mdx mice
following eccentric contractions.
Recent studies have suggested that stretch-activated
cation channels (calcium or sodium) at the sarcolemma
contribute to force loss during eccentric contractions
[12-15]. The removal of calcium in the muscle-bathing
media or the addition of streptomycin to block stretch-
activated channels has been shown to reverse or attenu-
ate force loss during injurious muscle contractions in
dystrophic muscle [12,15-17]. Store-operated calcium
entry (SOCE) is an important mechanism whereby cal-
cium is brought into muscle cells during sarcoplasmic
reticulum (SR) calcium depletion [18]. It has been pro-
posed that SOCE occurs through either (1) an interac-
tion between transient receptor potential C (TRPC)
channels and either the ryanodine receptor or inositol
trisphosphate receptors or (2) the STIM1/Orai1 pathway
[19]. TRP channels are plasma membrane channels that
vary in cation selectivity and sensitivity to mechanical
stress. While TRP gene transcripts are generally in low
abundance in skeletal muscle compared to some other
tissues, TRPC3 is the most abundant, with TRP vanilloid
3 (TRPV3), TRPV4, TRPV6, TRP melastatin 3 (TRPM3),
TRPM4 and TRPM7 also present [20]. In fact, the over-
expression of dominant-negative TRPC3 or TRPV2
channels in muscle ameliorates pathological changes
[13,21,22], and TRPC3 overexpression in WT mice is
sufficient to induce muscular dystrophy [22]. mdx mice
that overexpress a dominant-negative TRPV2 channel
are also protected from extreme force loss following
eccentric muscle contractions [13].
Although g-cyto actin comprises only 1/4, 000th of the
actin population in skeletal muscle [23], it is essential
for the maintenance of normal muscle function in adults
[ 2 4 ] .W ep r e v i o u s l yr e p o r t e dt h a tg-cyto actin levels are
elevated fivefold in dystrophin-deficient skeletal muscle
[23,25,26] and that muscle-specific ablation of g-cyto
actin does not exacerbate the dystrophic condition [26].
As many costameric components are actin-binding pro-
teins, it has been proposed that this increased g-cyto
actin expression may contribute to a compensatory
remodeling response to reinforce the compromised sar-
colemma in mdx mice [23]. Understanding the function
of increased g-cyto actin in dystrophic muscle may iden-
tify a unique pharmacological target for the treatment of
muscular dystrophies. The purpose of this study was to
determine whether further elevation of g-cyto actin levels
improves or exacerbates the dystrophic phenotype of
mdx mice. We generated a line of transgenic mdx mice
(mdx-TG) that expressed g-cyto actin 200-fold above
mdx g-cyto actin levels and showed substantial incor-
poration of g-cyto actin into thin filaments. Interestingly,
mdx-TG mice showed significantly attenuated force loss
during eccentric muscle contractions through a mechan-
ism independent of extracellular calcium and stretch-
activated channels.
Methods
Generation of transgenic mice
Generation of Actg1-TG mice has been previously
described [27]. To generate dystrophin-deficient mdx-
TG mice carrying the Actg1 transgene, Actg1-TG male
mice were crossed with mdx females. TG-positive males
were subsequently crossed with mdx females to generate
mdx-TG mice. Animals were housed and treated in
accordance with the standards set by the Institutional
Animal Care and Use Committees at the University of
Minnesota and the University of Wisconsin.
Determination of g-cytoplasmic actin concentration in
skeletal muscle
Known amounts of purified bovine brain actin [27] and
SDS extracts from mdx-TG gastrocnemius or quadriceps
femoris muscles were run side-by-side on a 3% to 12%
SDS-polyacrylamide gel and transferred to nitrocellulose
membrane. Two g-cyto actin antibodies (monoclonal
mouse 2 to 4 and polyclonal affinity-purified rabbit
7577) were used for Western blot analysis, each at a 1:1,
000 dilution. To determine the concentration of actin
Baltgalvis et al. Skeletal Muscle 2011, 1:32
http://www.skeletalmusclejournal.com/content/1/1/32
Page 2 of 13(in micrograms) in the SDS extracts, a concentration
standard curve was derivedf r o mt h ek n o w nv a l u e so f
purified bovine g-cyto actin using the densitometry and
concentration standards feature in the LI-COR Odyssey
Application Software version 2.1.12 (LI-COR Bios-
ciences, Lincoln, NE, USA).
Skeletal muscle histology and confocal microscopy
Tibialis anterior (TA) and gastrocnemius muscles from
WT, mdx and mdx-TG mice were frozen in melting iso-
pentane and mounted in O.C.T. mounting medium for
cryosectioning [27]. Ten-micrometer sections were
stained with hematoxylin and eosin. Centrally nucleated
fibers (CNFs) were counted on whole sections and
expressed as a percentage of the total number of fibers.
Isolation of myofibrils and confocal microscopy were
both performed as previously described [27]. Cross-sec-
tions of gastrocnemius muscles or myofibrils were
stained using the following antibodies: affinity-purified
g-cyto actin rabbit 7577 (1:75 dilution; Sigma, St Louis,
MO, USA), fast myosin heavy chain clone MY-32 (1:100
dilution; Sigma) and laminin a-2 rat clone 4H8-2 (1:200
dilution; Sigma). All images were obtained using a Fluo-
View FV1000 single-photon confocal microscope
equipped with a PlanAPO 60×/1.40 na oil immersion
lens objective, a UPlan Fluorite N 1.30 NA 40× oil
immersion lens objective and a UPLSAPO 0.40 NA 10×
lens objective (all from Olympus America Inc, Melville,
NY, USA). Images were collected with Olympus Fluo-
View FV1000 version 1.7b software and assembled and
processed using ImageJ software (National Institutes of
Health, Bethesda, MD, USA) and Adobe Photoshop ver-
sion 8.0 software (Adobe Systems Inc, San Jose, CA,
USA).
Serum creatine kinase analysis
Serum was collected and stored at -80°C until analysis.
Ten microliters of serum were applied to a VITROS
DT60 II MicroSlide (Ortho-Clinical Diagnostics, Inc,
Rochester, NY, USA) and creatine kinase (CK) activity
measured using a Kodak Ektachem DT60 Analyzer
(Eastman Kodak Co, Rochester, NY, USA) and a
VITROS DTSC II Module (Ortho-Clinical Diagnostics,
Inc).
Ex vivo contractility measurements and eccentric injury
protocol
The extensor digitorum longus (EDL) muscles were
assessed for contractile function and susceptibility to
eccentric contraction-induced injury as previously
described [26,28]. Age-matched male mdx and mdx-TG
mice (n = 5 or 6 per group) were anesthetized with
sodium pentobarbital (100 mg/kg body weight). Their
muscles were dissected and mounted onto a dual-mode
muscle lever system (model 300B-LR Dual-Mode Lever
Arm; Aurora Scientific Inc, Aurora, ON, Canada) with
4-0 suture in a 1.5-ml bath assembly filled with Krebs-
Ringer bicarbonate buffer that was maintained at 25°C
and perfused with 95% O2. The muscles were adjusted
to their anatomic optimal length (Lo)b a s e do nr e s t i n g
tension of 0.4 g, and then muscle length was measured.
The muscles remained quiescent in the bath for ten
minutes. Passive stiffness, twitch force (Pt), tetanic force
(Po) and active stiffness were measured prior to initiat-
ing the eccentric injury protocol. First, passive stiffness
of the muscle was determined by stretching the muscle
sinusoidally from 97.5% Lo to 102.5% Lo at 0.5 Hz while
measuring the resulting force [29,30]. Two twitches (Pt)
separated by 30-second intervals were elicited, and the
resulting force was measured. Maximal isometric tetanic
contractions (Po) were obtained by stimulating muscles
for 400 ms at 180 Hz and 150 V (Grass S48 Square
Pulse Stimulator; Grass Technologies, West Warwick,
RI, USA) delivered through a SIU-V stimulus isolation
unit (Grass Technologies). Two minutes later a second
tetanic isometric contraction was elicited, and at peak
force a sinusoidal length oscillation of 0.01% Lo at 500
Hz was imposed to determine active stiffness, an indir-
ect marker of strong-binding myosin [29,30]. Two min-
utes after that an injury protocol consisting of five to
ten eccentric contractions was begun. For these contrac-
tions, muscles were passively shortened from Lo to 0.95
Lo over 3 seconds, stimulated tetanically for 200 ms as
the muscle lengthened to 1.05 Lo at 0.5 Lo/second and
then passively returned to Lo. Each eccentric contraction
was separated by three minutes of rest. The degree of
injury was calculated as the percentage change in
eccentric force production from the first to the last
eccentric contraction. Specific force was calculated by
dividing isometric force by the anatomical cross-sec-
tional area of the muscle. The cross-sectional area of
the muscle was calculated by dividing the mass of the
muscle by the product of fiber length (Lf)( L o × 0.44)
and the density of muscle (1.06 g/mm
3). Contractility
and injury protocols were followed to study both the
right and left sides and averaged as a single data point
for each mouse when comparing mdx and mdx-TG
mice.
To determine the effects of extracellular calcium and
stretch-activated channels on the susceptibility to
eccentric contraction-induced injury, three different
conditions were tested, all using male mdx mice, with
the contralateral muscle from the same mouse used as a
control (n = 3 to 5 per group). In the first condition,
Krebs-Ringer bicarbonate buffer was made without
CaCl2 but replaced with the same molar ratio of MgCl2
(that is, calcium-free). In the second condition, 1 mM
ethylene glycol tetraacetic acid (EGTA) was added to
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blunted isometric force production, so buffer containing
1 mM EGTA was introduced only after the preinjury
contractile measurements were completed. The muscle
remained quiescent for ten minutes after the addition of
the calcium-free buffer with EGTA before the eccentric
contraction protocol was begun. In the third condition,
2 mM streptomycin was added to Krebs-Ringer bicarbo-
nate buffer for the entire protocol. Pilot work revealed a
greater effect on postinjury isometric force production
with the 2 mM concentration instead of the previously
reported 0.2 mM [12].
Flexor digitorum brevis myofiber isolation
Flexor digitorum brevis (FDB) fibers were isolated from
WT and mdx mice as previously described [31-33]. The
right and left FDB muscles were dissected from WT,
mdx and mdx-TG mice and placed in 5 ml of sterile
physiological rodent saline (138 mM NaCl, 2.7 mM KCl,
1.8 mM CaCl2,1 . 0 6m MM g C l 2, 12.4 mM 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (HEPES), 5.6
mM glucose, pH 7.3). The muscles were then trans-
ferred to a Petri dish containing 2 ml of media (DMEM,
10% fetal bovine serum, and 0.5% penicillin/streptomy-
cin) containing 2 mg/ml collagenase. Following this
step, they were incubated at 37°C (5% CO2)f o rt h r e e
hours and then gently triturated in fresh media and
allowed to settle at 1 × g. All but 1 ml of the media was
aspirated, and the fiber pellet was gently resuspended.
Next the fibers were placed into six 35-mm Petri dishes,
each containing a glass coverslip coated with 1 μgo f
laminin supplemented with 2 ml of media. The fibers
were allowed to adhere to the coverslips overnight at
37°C. They were analyzed for SOCE within 24 to 48
hours after dissection.
Store-operated calcium entry
SOCE was measured in FDB fibers as previously
described [22,34]. Coverslips containing adhered FDB
fibers were briefly washed in physiological saline solu-
tion (PSS) (130 mM NaCl, 5.6 mM KCl, 1 mM MgCl2,
1.7 mM CaCl2, 11 mM glucose, 10 mM HEPES, pH
7.4). Indo-1 AM (Invitrogen, Carlsbad, CA, USA) was
mixed 1:1 with Pluronic F-127 solution (Invitrogen) and
added to myofibers at a final concentration of 1 μM.
Myofibers were loaded with dye for 30 minutes at 37°C
and washed with PSS for 15 minutes at 37°C. Instru-
mentation and recording of the calcium signal was per-
formed as previously described [35]. Myofibers were
perfused with PSS at a rate of 1 to 2 ml/minute for two
minutes before being moved to calcium-free PSS. The
calcium-free PSS did not contain CaCl2,h a daM g C l 2
concentration of 2 mM, contained 1 mM EGTA and
contained 30 μM cyclopiazonic acid (CPA) to block SR
calcium-ATPase. Calcium-free PSS was perfused for
four to eight minutes before 5 mM caffeine was added
to release calcium from the SR. After the indo-1 ratio
had returned to baseline (8 to 12 minutes), the muscle
was perfused with PSS and SOCE was calculated as the
difference in the minimum and maximum indo-1 ratios
averaged over a 30-second period. During the recording
of the indo-1 signal, 50 μM N-benzyl-p-toluene sulfona-
mide (BTS) was added to all solutions to prevent myofi-
ber contractions.
Data analysis
T w o - w a ya n a l y s i so fv a r i a n c e( A N O V A )w a su s e dt o
assess differences in CNFs and serum CK with mouse
strain (WT vs mdx vs mdx-TG) and age as the factors.
One-way ANOVA was used to compare intracellular
calcium concentration ([Ca
2+]i) between WT, mdx and
mdx-TG mice. Post hoc analyses were performed using
the Holm-Sidak test. t-tests were used to analyze differ-
ences between all other variables. Data are reported as
means ± SEM. Significance was set at P < 0.05.
Results
To examine the role of elevated g-cyto actin in dystro-
phin-deficient muscle, Actg1-TG male mice were
crossed with mdx female mice. Levels of g-cyto actin in
mdx-TG skeletal muscle SDS extracts were analyzed
alongside a purified g-cyto actin calibration curve on
SDS-PAGE gels and blotted with g-cyto actin-specific
antibodies. Mean (± SEM) mdx-TG g-cyto actin levels in
muscle were 397 ± 53 μM, which is approximately 200-
fold that in mdx skeletal muscle and similar to that in
skeletal muscles of Actg1-TG mice (Figure 1A).
To determine the localization of g-cyto in mdx-TG ske-
letal muscle, cross-sections were stained with an affinity-
purified g-cyto actin antibody. Capillaries, blood vessels,
nerves and immune cells stained brightly in mdx skeletal
muscle (Figure 1B). In addition, the internal structure of
mdx-TG muscle showed intense g-cyto actin localization
as previously described [27] for Actg1-TG mice (Figure
1B). Internal staining of g-cyto actin was prominent in
the majority of fibers. Staining of isolated mdx-TG myo-
fibrils showed g-cyto actin incorporation into the thin
filament that was absent in mdx myofibrils (Figure 1C).
Colocalization of g-cyto actin with fast myosin heavy
chain is consistent with reports that the human a-skele-
tal actin promoter used to drive transgene expression is
preferentially active in fast-twitch muscle fibers [27,36].
To determine whether elevated levels of g-cyto actin
were beneficial or detrimental to dystrophin-deficient
skeletal muscle, several well-established parameters of
dystrophic pathology were examined. Hematoxylin and
eosin-stained skeletal muscle cross-sections from mdx
and mdx-TG mice were indistinguishable, showing
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and mononuclear cell infiltration (Figure 2A). In addi-
tion, mdx mice exhibited high levels of CNFs and ele-
vated serum CK. CNF levels were quantified in
gastrocnemius and TA muscles at various ages (Figure
2B). As expected, mdx and mdx-TG mice had greater
CNFs in the TA muscle (P < 0.001) and the gastrocne-
mius muscle (P <0 . 0 0 1 )c o m p a r e dt oW Tm i c e .I nt h e
TA muscle, there was a significant interaction between
mouse group and age (P < 0.001). mdx-TG mice had
37% fewer CNFs in the TA muscle at one month of age
compared to mdx mice, but there were no differences in
CNFs between mdx and mdx-TG mice at any other ages
for the TA muscle (P > 0.155) or the gastrocnemius
muscle (P = 0.793). Serum CK levels were elevated in
dystrophic compared to WT mice (P ≤ 0.013) but were
Figure 1 g-cytoplasmic actin expression in skeletal muscle and incorporation into thin filaments. (A) Quantitative Western blot analysis of
g-cytoplasmic (g-cyto) actin levels in SDS extracts of mdx-TG murine skeletal muscle. Values are means +/- SEM. *Previously published values
[23,27]. (B) g-cyto actin expression in mdx and mdx-TG gastrocnemius muscle cross-sections. (C) g-cyto actin expression in thin filaments. Isolated
myofibrils were costained with antibodies against g-cyto actin and fast myosin heavy chain.
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of age (P = 0.463) (Figure 2B).
We previously demonstrated that Actg1-TG mice
exhibit normal ex vivo and in vivo muscle performance,
despite replacing 40% of the contractile a-skeletal actin
population with g-cyto actin [27]. In EDL muscles from
mdx-TG mice, passive stiffness was 27% less and wet
mass was 13% less than those from the EDL muscles of
mdx mice. There were no differences in any other para-
meters of isometric contractility including Pt,P o, specific
force, rate of contraction, rate of relaxation, time to Pt
or one-half relaxation time when g-cyto actin was overex-
pressed in dystrophic muscle (P ≥ 0.140) (Table 1). Most
interestingly, when isolated EDL muscles from mdx and
mdx-TG mice were subjected to a series of ten eccentric
contractions, force loss was attenuated in mdx-TG mice
during contractions 2 through 7 (P ≤ 0.044) (Figure 3A).
The reduced susceptibility to injury in the mdx-TG
mice was not due to lower force production, because




Figure 2 Overexpression of g-cytoplasmic actin does not alter muscle pathology or serum creatine kinase. (A) Representative muscle
tissue cross-sections from mdx and mdx-transgenic (mdx-TG) mice (hematoxylin and eosin stain). (B) Centrally nucleated fibers (CNFs) in tibialis
anterior (TA) and gastrocnemius muscles and serum creatine kinase (CK) levels from wild-type (WT), mdx and mdx-TG mice at 4 to 52 weeks of
age. *Statistically significant difference from WT. #Statistically significant difference from mdx. &Statistically significant difference from WT (main
effect of strain).
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pared to mdx mice (P ≤ 0.041) (Figure 3B). We followed
up this experiment by testing susceptibility to injury in
younger mdx and mdx-TG mice and also by decreasing
the number of eccentric contractions. One-month-old
mdx-TG mice also demonstrated attenuated force loss
during eccentric contractions (Figure 3C), although the
phenotype was not quite as robust. Postinjury isometric
contractile measurements in one-month-old mdx-TG
mice showed less isometric force loss and less eccentric
force loss compared to mdx mice (P ≤ 0.018) (Figure
3D). There were also trends toward reduced passive
stiffness (P = 0.071) and active stiffness (P = 0.070) fol-
lowing injury in mdx-TG mice compared to mdx mice.
The protection afforded by g-cyto actin could be mani-
fested through many mechanisms. We were intrigued by
how similar our data were to those reported by Zanou
et al. [13], who demonstrated that mdx mice with high
levels of a dominant-negative TRPV2 channel were pro-
tected from contraction-induced injury, despite having
normal isometric and eccentric force generation and
smaller EDL muscles. These results resemble ours from
mice overexpressing g-cyto actin. Therefore, we designed
experiments to test the hypothesis that overexpression
of g-cyto actin reduces the function of stretch-activated
channels to prevent abnormal influx of calcium during
eccentric contractions. Since there has been some con-
troversy whether SOCE and TRP channel functions are
perturbed in mdx muscle, we first examined SOCE in
isolated FDB fibers from WT mice (Figure 4A), mdx
mice (Figure 4B) and mdx-TG mice (Figure 4C). Muscle
contraction was blocked by the addition of BTS. Basal
[Ca
2+]i was significantly less in mdx f i b e r s( 3 5±6n M )
and mdx-TG fibers (36 ± 3 nM) compared to WT fibers
(62 ± 5 nM; P = 0.002) (Figure 4D). The SR was
depleted of calcium by application of CPA and caffeine
in calcium-free PSS. SOCE was evoked by returning cal-
cium to the bath (Figure 4E). In WT fibers, SOCE pro-
duced a minor detectable [Ca
2+]i increase (30 ± 3 nM).
This response was more variable in mdx fibers (66 ± 20
nM) and mdx-TG fibers (102 ± 55 nM), but these mean
values were not statistically different from WT fibers (P
= 0.085). The peak [Ca
2+]i following the replacement of
the perfusate with calcium was not different between
WT mice (96 ± 7 nM), mdx mice (113 ± 20 nM) and
mdx-TG mice (134 ± 54 nM; P = 0.968).
This result prompted us to examine the effect of
extracellular calcium and stretch-activated channels on
force loss during eccentric contractions in intact mdx
EDL muscles. First, we substituted MgCl2 for CaCl2 in
the bath during contractions, which did not attenuate
force loss (Figure 5A). Second, we used the same cal-
cium-free buffer and added 1 mM EGTA to chelate any
contaminating calcium. Instead of preventing force loss,
muscles bathed in a calcium-free buffer with EGTA lost
more force at the second eccentric contraction (P =
0.013) (Figure 5B). In the third experiment, 2 mM strep-
tomycin was added to the Krebs-Ringer bicarbonate buf-
fer to block stretch-activated channels. Streptomycin did
not affect eccentric force loss at any eccentric contrac-
tion (P ≥ 0.088) (Figure 5C).
It is important to consider whether the removal of cal-
cium or the addition of EGTA or streptomycin affected
i s o m e t r i co re c c e n t r i cf o r c ep r o d u c t i o n ,b e c a u s es u c h
effects would consequently affect force loss. Specific iso-
metric force production was unaffected by the removal
of calcium or the addition of streptomycin (P ≥ 0.139)
(Figure 6A). Pilot work showed that EGTA affected iso-
metric force, so the calcium-free buffer containing
EGTA was added to the bath after we took isometric
measurements in normal Krebs-Ringer bicarbonate buf-
fer. However, specific eccentric force production of
muscles bathed in a calcium-free solution containing
EGTA was approximately 50% less than that in normal
Krebs-Ringer bicarbonate buffer (P = 0.014) (Figure 6B).
Interestingly, although eccentric force loss by the fifth
contraction was not altered in any of the different buf-
fers, isometric force production measured three minutes
after the last eccentric contraction was either 44% or
53% of that of control muscles in muscles bathed in a
calcium-free buffer with or without EGTA, respectively.
Conversely, muscles bathed with streptomycin had
greater isometric force nearly threefold that of control
muscles.
Table 1 Isometric contractile properties of extensor
digitorum longus muscles from four-month-old mdx and
mdx-TG mice
Contractile properties mdx (n =6 ) mdx-TG (n =6 ) P value
EDL mass (mg) 15.8 ± 0.8 13.7 ± 0.5 0.043*
Lo (mm) 11.9 ± 0.2 12.2 ± 0.1 0.205
CSA (cm
2) 0.028 ± 0.001 0.024 ± 0.001 0.009*
Passive stiffness (N/m) 19.6 ± 1.6 14.2 ± 0.9 0.018*
Active stiffness (N/m) 714.8 ± 40.1 738.7 ± 98.3 0.826
Pt (mN) 59.6 ± 5.6 65.7 ± 8.1 0.593
TPT (ms) 17.9 ± 0.4 18.3 ± 0.4 0.556
RT1/2 (ms) 21.4 ± 1.3 19.1 ± 0.7 0.161
Specific Pt (N/cm
2) 2.1 ± 0.2 2.8 ± 0.4 0.153
Po (mN) 264.0 ± 21.5 288.6 ± 39.1 0.593
+dP/dt (N/s) 7.15 ± 0.63 7.68 ± 0.95 0.648
-dP/dt (N/s) 10.9 ± 1.2 13.0 ± 2.4 0.458
Specific Po (N/cm
2) 9.1 ± 0.6 12.2 ± 1.8 0.140
Values are means ± SEM. CSA = cross-sectional area; +dP/dt = maximum rate
of tetanic force development; -dP/dt = maximum rate of relaxation; EDL =
extensor digitorum longus; Lo = optimal length; Po = peak tetanic force; Pt =
peak twitch force; RT1/2 = one-half relaxation time; TG = transgenic; TPT =
time to peak twitch force. *Statistically significant difference from mdx.
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We are just beginning to understand the roles of cyto-
plasmic actin isoforms in skeletal muscle. Nonmuscle g-
cyto actin plays a vital role in muscle maintenance, as its
ablation results in the accumulation of CNFs and hin-
d l i m bc o n t r a c t u r e s[ 2 4 ] .I nd y s t r o p h i cm u s c l e ,g-cyto
actin levels are elevated five- to tenfold compared to
WT muscle, compensating for a weakened DGC and
sarcolemma [23,25]. When transgenically overexpressed
2, 000-fold (about 400 μM) in WT mice, g-cyto actin
incorporated into myofibrils but had no effect on iso-
metric force generation, muscle fiber size or the inci-
dence of CNFs [27]. Similarly, we found that g-cyto actin
overexpression in dystrophic muscle also did not affect
pathology, isometric force production or disease
progression.
Our most interesting finding is that g-cyto actin over-
expression significantly decreased the immediate force
loss caused by eccentric contractions in mdx muscle.
This protection was apparent at two different ages of
mice and was also associated with greater isometric
force generation at the end of the eccentric contractions.
Thus the protection afforded by g-cyto actin overexpres-
sion was not due to weakened muscles, as isometric
force production before the injury protocol was similar
between mdx and mdx-TG mice and four-month-old
mdx-TG mice actually generated greater eccentric force
in seven of ten eccentric contractions compared to mdx
mice. After eccentric contractions, EDL muscle mass
was less in mdx-TG mice than in mdx mice, and there
was a trend toward a greater passive stiffness increase in
mdx mice than in mdx-TG mice, possibly suggesting
reduced fluid accumulation as a consequence of muscle
damage. These results differ from our findings in WT
mice that Actg1-TG mice show a similar susceptibility
to injury following eccentric contractions. It is possible
Figure 3 g-cytoplasmic actin overexpression in mdx mice attenuates force loss during eccentric contractions. Eccentric contractions were
performed ex vivo in isolated extensor digitorum longus (EDL) muscles from mdx and mdx-TG mice at one and four months of age. (A) Force
loss expressed as a percentage of initial eccentric force in four-month-old mice. (B) Eccentric force generation at each contraction in four-
month-old mice. (C) Force loss in one-month-old mice. (D) Postinjury functional analyses of one-month-old mice. Data are means ± SEM.
*Statistically significant difference from mdx mice.
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corrects a mechanism associated with force loss in dys-
trophic muscle that is not present in WT muscle.
The mechanism of force loss following eccentric con-
tractions in dystrophic muscle is not understood but is
likely different from that in healthy muscle. For exam-
ple, in healthy muscle, excitation-contraction uncoupling
has been demonstrated to account for about 75% of the
deficit in muscle strength following eccentric contrac-
tions in vivo, with physical damage accounting for only
approximately 25% [11]. It has been postulated that
extracellular calcium plays an important role in activat-
ing calpains to cause protein degradation. Furthermore,
following excessive calcium entry into dystrophic mus-
cle, the mitochondria act as a sink to buffer elevated cal-
cium levels and consequently increase the production of
Figure 4 Store-operated calcium entry in flexor digitorum brevis myofibers. Representative calcium tracings in wild-type (WT) (A), mdx (B)
and mdx-transgenic (mdx-TG) (C) flexor digitorum brevis (FDB) fibers following sarcoplasmic reticulum (SR) depletion and add-back of calcium.
(D) Basal intracellular calcium concentration ([Ca
2+]i) in WT, mdx and mdx-TG FDB fibers. (E) [Ca
2+]i during store-operated calcium entry (SOCE).
Bars represent means ± SEM. *Statistically significant difference from WT mice.
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streptomycin does not affect immediate force loss during
eccentric muscle contractions in mdx mice. (A) Eccentric
contractions performed in calcium-free buffer (CaCl2 replaced with
MgCl2). (B) Eccentric contractions performed in calcium-free buffer
with the addition of 1 mM ethylene glycol tetraacetic acid (EGTA).
(C) Eccentric contractions performed in normal buffer with the
addition of 2 mM streptomycin. Data are means ± SEM. *Statistically
significant difference from Krebs-Ringer bicarbonate buffer.
Figure 6 Isometric specific force after eccentric contractions in
mdx mice is improved with streptomycin, but not in a calcium-
free buffer. (A) Isometric specific force before injury. (B) Eccentric
specific force of first eccentric contraction. (C) Isometric specific
force measured three minutes after eccentric contractions. Data are
means ± SEM. *Statistically significant difference from Krebs-Ringer
bicarbonate buffer.
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keleton can affect SOCE and interact with TRP channels
[40], we hypothesized that g-cyto actin’s protective effect
is due to its ability to attenuate extracellular calcium
entry during eccentric contractions. Although mdx and
mdx-TG mice appeared to have a slightly greater SOCE
response than WT mice, we were unable to detect a dif-
ference between the three genotypes. In fact, the peak
[Ca
2+]i was not different between the genotypes, sug-
gesting that any potential differences in SOCE were due
to differences in basal [Ca
2+]i. Our data differ from
those reported by others who also used a calcium dye
with other dystrophic models, such as mdx
5Cv and sar-
coglycan δ-null mice [22,34]. The mdx
5Cv mouse has
fewer revertant fibers and an overall phenotype that is
more severe than the mdx mouse [41]. It is quite possi-
ble that calcium influx during store depletion is a phe-
notype seen in some mouse models of muscular
dystrophy, but not in the mdx mouse.
Since we were not able to detect a difference in SOCE
in immobilized FDB fibers, we performed more physio-
logically relevant experiments by modifying extracellular
calcium or adding streptomycin to block stretch-acti-
vated channels to the muscle bath during ex vivo
eccentric muscle contractions of the EDL muscle, simi-
larly to previous work [12,14,15]. We found that
removal of CaCl2 or the blockade of stretch-activated
channels in the bathing media did not have an effect on
immediate force loss during eccentric contractions. Our
results are different from those previously published
[12,13,15-17], probably because of the muscles studied
(EDL vs FDB fiber or lumbrical muscle), differences in
protocol (length change and rest time between contrac-
tions), length of treatment (acute vs chronic manipula-
tion of genes) and calculation of force loss (eccentric vs
isometric and timing of measurement).
The most commonly used muscle for the assessment
of eccentric contraction-induced injury in mdx mice is
the EDL [10], which we used in the current study. One
previous study assessed the role of extracellular calcium
and stretch-activated channel blockers during injurious
muscle contractions in the EDL muscle [12], whereas all
others have used FDB fibers or the lumbrical muscles
[14-17]. It appears that isolated muscle fibers [14,15]
demonstrate a more robust response than intact muscles
to stretch-activated channel blockers [12]. Other studies
supporting a role for extracellular calcium in force loss
have been performed in the lumbrical muscle, using iso-
metric contractions instead of eccentric contractions
[16,17].
Another difference between this and previous studies
are the conditions of the eccentric injury protocol. Phy-
siological length changes in muscle in a previous study
were 20% or less [42]. Researchers in other studies who
have shown positive results by removing extracellular
calcium or blocking stretch-activated receptors used
length changes of 30% to 40% of Lo [12,14,15]. In the
current study, we were able to use a physiological length
change (Lo ± 5%) and still induce a significant amount
of force loss. It is possible that a nonphysiological length
change (more than 20% Lo) may stimulate a different
mechanism responsible for force loss that is not appar-
ent when the length change is relatively minor. The
number of contractions and the rest time between con-
tractions may also be important. The muscles in our
study were rested for three minutes between contrac-
tions to prevent fatigue. Investigators in other studies
have used rest periods ranging from 4 to 60 seconds
between contractions. These short rest times can cause
fatigue, which affects the amount of injury induced and
complicates interpretation. With our three-minute rest
period between contractions, we did not see any force
loss during isometric or concentric contractions (data
not shown).
Recent studies have suggested that TRP channels con-
tribute to the dystrophic phenotype and contraction-
induced injury [13,21,22]. Dystrophic mice harboring a
dominant-negative TRPV2 or TRPC3 channel transgene
show improved CK, fiber size variability, CNFs and sus-
ceptibility to contraction-induced injury [13,21,22]. In
our study, acute blockage of stretch-activated channels
with 2 mM streptomycin did not attenuate eccentric
force loss. Mice that chronically overexpress a domi-
nant-negative TRPV2 channel show improvement in
CK, CNFs and contraction-induced injury [13,21]. Per-
haps chronic blockade of TRP channels leads to a heal-
thier muscle, which indirectly results in protection from
eccentric contractions.
It is also imperative to describe how force loss is cal-
culated after eccentric contractions. Herein we report
both eccentric force loss and isometric force loss.
Although zero extracellular calcium or the addition of
streptomycin had no effect on overall eccentric force
loss, isometric force loss measured three minutes after
the last eccentric contraction was significantly less in
the zero calcium buffer but about threefold higher when
treated with streptomycin. The reason for these dispa-
rate results may lie in the timing of the force measure-
ments after injury. Whitehead et al.[ 1 2 ]d i dn o tr e p o r t
differences in eccentric force loss immediately after
injury, but rather differences in isometric force loss 30
minutes after the last eccentric contraction when bath-
ing EDL muscles in 0.2 mM streptomycin, which is
similar to our finding. During that time, isometric force
recovered from less than 10% of preinjury force to 34%
to 44% of preinjury torque. We suggest that blocking
stretch-activated channels enhances the recovery of
muscle following eccentric contractions. Since some
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and zero extracellular calcium actually resulted in
reduced isometric force (with or without EGTA), the
effect of streptomycin on the recovery of force may be
independent of calcium.
Conclusions
Our results provide new insig h ti n t ot h em e c h a n i s mo f
contraction-induced injury in dystrophic muscle. First,
g-cyto actin overexpression can protect muscles from
eccentric contraction-induced injury independently of
any detectable improvement in dystrophic muscle
pathology or disease phenotype. Second, g-cyto actin
overexpression appears to act through a mechanism
independent of extracellular calcium or stretch-activated
channels. Our data also suggest that dysfunction of
stretch-activated cation channels is not involved in the
immediate force loss following eccentric contractions in
dystrophic muscle. Future studies will aim to determine
the biochemical and biophysical properties of thin fila-
ments, myofibrils and myofibers composed of different
actin isoforms to gain understanding of how altered
actin isoform composition translates into altered muscle
function.
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